Clinical
Our clinical business offers a range of services specific to early drug development. Specialising in Phase I/IIa studies, drug product optimisation and 14C enabled drug development services, we can provide full clinical support for your early drug development programmes.
Clinical Services
We offer a range of clinical services including:
- Phase I/IIa
- Drug Product Optimisation
- 14C Enabled Drug Development
Clinical Capabilities
As your partner in early clinical studies, we can support you in all areas of early drug development, from pharmaceutical sciences, tailored regulatory support and on-site Qualified Persons (QPs) through to biometrics and reporting. Read more.
Unique Clinical Platforms
We have developed a number of unique platforms to expedite your drug development programme and add value to your drug candidates. Learn more about Translational Pharmaceutics™, Synthesis-to-Clinic™, Enterion™ drug absorption studies and scintigraphic imaging.
Contact us to find out more and to discuss your specific needs.